Tze Khee Chan

17 papers receiving 1.1k citations

Hit Papers

Artemisinins: Pharmacological actions beyond anti-malarial20132026201720212013100200300

Peers

Tze Khee Chan
Comparison fields: 5 of 102
  • Molecular Biology 438
  • Immunology 255
  • Complementary and alternative medicine 248
  • Public Health, Environmental and Occupational Health 140
  • Epidemiology 134
Replace Hong Yong Peh with:
Hong Yong Peh Singapore
Wanxing Eugene Ho Singapore
Yongling Lu China
Ewa Skopińska-Różewska Poland
Hao Pan China
Bei Tong China
Hiroo Toyoda Japan
Utpala Chattopadhyay India
Dagmar Barz Germany
Tze Khee Chan relative to Hong Yong Peh Singapore Hong Yong Peh's profile →
Citations per field
00.5×1.5×1.9×
Hong Yong Peh · 1×
Citations per year

Countries citing papers authored by Tze Khee Chan

Since Specialization
Citations

This map shows the geographic impact of Tze Khee Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tze Khee Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tze Khee Chan more than expected).

Fields of papers citing papers by Tze Khee Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tze Khee Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tze Khee Chan. The network helps show where Tze Khee Chan may publish in the future.

Co-authorship network of co-authors of Tze Khee Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Tze Khee Chan. A scholar is included among the top collaborators of Tze Khee Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tze Khee Chan. Tze Khee Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 11
2 7
3 80
4 38
5 39
6 10
7 111
8 81
9 33
10 2
11 38
12 54
13 42
14 2
15 7
16
Artemisinins: Pharmacological actions beyond anti-malarialbreakdown →
385
17 223

About Tze Khee Chan

Tze Khee Chan is a scholar working on Microbiology, Immunology and Immunology and Allergy, having authored 17 papers that have together received 1.2k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (5 papers), Immune Cell Function and Interaction (4 papers) and Antimicrobial Peptides and Activities (3 papers). The work is most often cited by research in Complementary and alternative medicine (248 citations), Immunology (255 citations) and Pharmacology (103 citations). Tze Khee Chan has collaborated with scholars based in Singapore, United States and United Kingdom. Frequent co-authors include W.S. Fred Wong, Hong Yong Peh, Wanxing Eugene Ho, David S.W. Ng, W.S. Daniel Tan, Sreenivasa Rao Sagineedu, Jonathan Chee Woei Lim, Johnson Stanslas, Bevin P. Engelward and Wupeng Liao. Their work appears in journals such as The Journal of Immunology, Scientific Reports and Free Radical Biology and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026